Epoch on November 6th | Vaccine manufacturer novavax has reached a termination and settlement agreement with the United Kingdom Health Security Agency (UKHSA) on the supply issues of its COVID-19 vaccine. Under the settlement agreement, the company will refund 0.1238 billion US dollars to health institutions over the course of three years.
诺瓦瓦克斯医药与英国就终止供应COVID-19疫苗达成和解
Novavax has reached a settlement with the United Kingdom on terminating the supply of COVID-19 vaccines.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated